On June 26, WuXi AppTec rose 3.38% in regular trading, trading at HK$148.0/share, with turnover of HK$264 million.

On the news front, the company has been conducting consecutive daily A-share buybacks of approximately RMB 100 million each, with its cumulative RMB 1 billion buyback program nearing completion. Meanwhile, institutional positioning signals remain positive: UBS has increased its H-share stake to 8.03%, while JPMorgan has reduced its short position from 3.11% to 2.34%, reflecting diminished bearish conviction among major global institutions.

The broader CXO and innovative drug sector continues to recover, with peer Pharmaron gaining 3.88% in the same session. The company's A-shares rose 1.58% in the prior trading session and had previously touched the daily limit up. The sustained buyback activity, combined with favorable institutional fund flows and sector-wide momentum, continues to underpin market confidence in the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)